HAEMOPHILUS The U.S. FDA approved Haemophilus type B vaccine on March 30, 1993. It belongs to the group of medicines called vaccines. It is used to protect against diseases caused by a bacteria called Haemophilus influenzae type B.

Haemophilus type B vaccine is used to treat diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, meningitis (serious diseases).

Haemophilus type B vaccine should be injected by a doctor and it should not be self administered. Your physician will decide the dosage and frequency of this injection based on the severity of your disease and other factors.

The common side effects that are experienced while you are on the treatment with Haemophilus type B vaccine are loss of appetite (anorexia), crying, sleepiness (somnolence), vomiting, fever, irritability, pain, redness, or swelling at the injection site or injection site hardness, abnormal crying (Infant), diarrhoea.

It is indicated to prevent disease caused by Haemophilus influenzae type B for infants and children from 6 weeks to 5 years of age. The dosing and booster doses depend on your child’s age. It is not recommended for pregnant or breastfeeding women.

It is indicated to prevent disease caused by Haemophilus influenzae type B for infants and children from 6 weeks to 5 years of age. The dosing and booster doses depend on your child’s age. Inform your doctor if you are allergic to the ingredient or any of the vaccine or a history of allergic reaction. Consult your doctor if you are planning to get pregnant or think you may be pregnant or while you are breastfeeding.

It is recommended to inform your doctor if you have a brain, blood, respiratory, kidney disorder before using the medicine. Consult your doctor if you have a fever before taking the medicine. Inform your doctor immediately if you have difficulty in breathing, blueness of the tongue or lips, rash, swelling of the face or throat, sudden and serious malaise with drop in blood pressure causing dizziness and loss of consciousness, accelerated heart rate associated with respiratory disorders. 

1. Sanofi Pasteur SA, US Food and Drug administration, [ Revised on March 2022], [Accessed on Oct2023], https://www.fda.gov/media/74395/download#:~:text=ActHIB%C2%AE%20is%20a%20vaccine,through%205%20years%20of%20age.
2. Roberto Tinoco and James E. Crowe, Jr., Immunoglobulins and Vaccines, Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th Edition, 2018, 655-672.

The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details consult your doctor about your medical condition to know if you are eligible to receive this treatment.